The effectiveness of vaccines may not be apparent in the short term.
REPUBLIKA.CO.ID, JAKARTA – Minister of Research and Technology / Head of the National Research and Innovation Agency Bambang PS Brodjonegoro said one of the program challenges vaccination Covid-19 is the effectiveness and safety of the Covid-19 vaccine. The effectiveness of vaccines may not be apparent in the short term.
“The effectiveness and safety of vaccines may not necessarily be seen in the short term, meaning that many people when the first vaccination was carried out yesterday, January 13, 2021, many were worried that many were afraid and all kinds and then when they felt it was okay, they felt that oh already. correct even though its effectiveness and safety may only be seen in the medium term, for example weekly or monthly, “he said in the webinar” Challenges and Policies for Red and White Vaccine Development to Accelerate Handling the Covid-19 Pandemic “in Jakarta, Friday.
Another challenge, he said, is related to protection against infection and the onset of moderate disease symptoms. In essence, the immunity generated by the Covid-19 vaccine may not last a lifetime. So it needs revaccination which of course also has to take into account the mutations of the corona virus that causes Covid-19 in the future.
According to Bambang, awareness of the importance of protection through vaccination to prevent Covid-19 infection is important and of course the quality of vaccines must guarantee the protection provided.
By carrying out the Covid-19 vaccination, it is hoped that it will reduce deaths and cases due to Covid, protect and strengthen the public health system, maintain productivity and restore the community’s economy, and achieve group immunity and protect the population.
In the virtual seminar, Minister of Research and Technology Bambang also explained the challenges faced in the development of the Covid-19 vaccine. These challenges are the evolution of new strains, the possibility of mutations, the selection of a vaccine development platform, as well as setting up manufacturing operations including production capacity, it takes time.
source: Between
– .
